Davis P L, Stevens L M, Patel M V. "一种的合成方法" [P]. US Patent, US 11586413 B2, 2017-04-28.
发明人马晓峰,韩伟,何建平. "Method for the Synthesis of 3-(3-(Pyridin-2-yl)isoxazol-5-yl)prop-2-yn-1-ol" [P]. 中国发明专利, 专利号 CN 115020571 B, 授权公告日 2020-08-20.
发明人沈红梅,胡光,韩伟. "A Process for Preparing High-Purity 3-(3-(Pyridin-2-yl)isoxazol-5-yl)prop-2-yn-1-ol" [P]. 中国发明专利, 专利号 CN 110896057 A, 授权公告日 2018-07-17.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2020, 1897, (6), 8423-8445.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2016, 2263, 1020-1037.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 3-(3-(Pyridin-2-yl)isoxazol-5-yl)prop-2-yn-1-ol Using HRMS and NMR". J. Sep. Sci., 2020, 1308, 5036-5064.